Proximagen

Proximagen is a company engaged in small molecule drug discovery and focused on research and development of central nervous system disorders. The Company develops drug candidate programs for various therapeutic areas, including epilepsy, Parkinson’s and Alzheimer’s diseases, inflammation, oncology, and neuropathic pain.